LPL Financial »

4d Molecular Therapeutics In shares owned by LPL Financial

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by LPL Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $166k 12k 13.30

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr Series Trust St Str P500etf (SPYM)
Spdr Series Trust ST STR P500GRW (SPYG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Capital Group Dividend Value Shs Creat Unit (CGDV)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Us Treas Bd Etf (GOVT)

View all positions for LPL Financial

Top funds holding 4d Molecular Therapeutics In

Jupiter Topco
Henderson Group
RA Capital Management
BlackRock
Goldman Sachs Group
Novo A/S
BVF
State Street Corporation
Adage Capital Partners GP
Trails Edge Capital Partners
Vanguard Capital Management
Armistice Capital
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In